Actinium Pharmaceuticals reported $16.64M in Operating Expenses for its fiscal quarter ending in March of 2025.





Operating Expenses Change Date
AbbVie USD 10.81B 13.45B Dec/2025
Actinium Pharmaceuticals USD 16.64M 9.13M Mar/2025
Amgen USD 5.9B 773M Dec/2025
Bioline Rx USD 2.63M 24K Sep/2025
Capricor Therapeutics USD 24.98M 6.15M Mar/2025
Pfizer USD 12.91B 79.89B Dec/2025